Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice

被引:77
作者
Jansen, WTM
Hogenboom, S
Thijssen, MJL
Kamerling, JP
Vliegenthart, JFG
Verhoef, J
Snippe, H
Verheul, AFM
机构
[1] Univ Utrecht Hosp, Vaccines Sect, Eijkman Winkler Inst Microbiol Infect Dis & Infla, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Bijvoet Ctr, Dept Bioorgan Chem, NL-3584 CH Utrecht, Netherlands
关键词
D O I
10.1128/IAI.69.2.787-793.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity and protective capacity of Streptococcus pneumoniae 6B capsular polysaccharide (PS)derived synthetic phosphate containing disaccharide (Rha-ribitol-P-), trisaccharide (ribitol-P-Gal-Glc-), and tetrasaccharide (Rha-ribitol-P-Gal-Glc-)-protein conjugates in rabbits and mice were studied. In rabbits, all saccharides conjugated to keyhole limpet hemocyanin (KLH) evoked high levels of pneumococcal (Pn) type 6B antibodies that facilitated type-specific phagocytosis. Unlike the disaccharide rabbit antisera, tri- and tetrasaccharide rabbit antisera also reacted with 6A PS in an enzyme-linked immunosorbent assay (ELISA) and promoted phagocytosis of 6A pneumococci. All these rabbit antisera passively protected mice against a Pn 6B challenge. The disaccharide conjugate-induced antiserum, however, failed to protect mice against a 6A challenge. In mice, phagocytic and protective anti-Pn 6B antibodies were only induced by the tetrasaccharide conjugate and not by PS 6B or PS 6B-protein conjugates. These antibodies did not cross-react with 6A PS in ELISA and were unable to phagocytize 6A pneumococci. In conclusion, the disaccharide and tetrasaccharide conjugates already contain epitopes capable of inducing 6B-specific, fully protective antibodies in rabbits and mite, respectively.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 34 条
[1]  
Alonso De Velasco E., 1993, Vaccine, V11, P1429
[2]  
Alonso de Velasco E, 1994, Infect Immun, V62, P799
[3]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[4]  
BORGONO JM, 1978, P SOC EXP BIOL MED, V157, P148, DOI 10.3181/00379727-157-40010
[5]   EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].
BREIMAN, RF ;
BUTLER, JC ;
TENOVER, FC ;
ELLIOTT, JA ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835
[6]   SEROTYPE DISTRIBUTION OF STREPTOCOCCUS-PNEUMONIAE INFECTIONS AMONG PRESCHOOL-CHILDREN IN THE UNITED-STATES, 1978-1994 - IMPLICATIONS FOR DEVELOPMENT OF A CONJUGATE VACCINE [J].
BUTLER, JC ;
BREIMAN, RF ;
LIPMAN, HB ;
HOFMANN, J ;
FACKLAM, RR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :885-889
[7]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[8]   CHARACTERIZATION OF THE MURINE IMMUNE-RESPONSE TO TYPE-6 PNEUMOCOCCAL POLYSACCHARIDE [J].
FAIRCHILD, RL ;
BRALEYMULLEN, H .
INFECTION AND IMMUNITY, 1983, 39 (02) :615-622
[9]   SEROTYPES OF STREPTOCOCCUS-PNEUMONIAE CAUSING DISEASE [J].
GRAY, BM ;
CONVERSE, GM ;
DILLON, HC .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (06) :979-983
[10]   Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies [J].
Jansen, WTM ;
Gootjes, J ;
Zelle, M ;
Madore, DV ;
Verhoef, J ;
Snippe, H ;
Verheul, AFM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (05) :703-710